COVID-19 Lockdown Tied to Increased Heavy Drinking
MONDAY, Dec. 7, 2020 -- Heavy alcohol consumption among adults with a history of binge drinking increases the longer they spend at home in lockdown during the COVID-19 pandemic, according to a study published online Dec. 7 in the American Journal of Drug and Alcohol Abuse.
Sitara Weerakoon, M.P.H., from the University of Texas Health Science Center in Dallas, and colleagues identified COVID-19-related stressors associated with change in alcohol consumption and binge drinking using data from an online survey of 1,982 U.S. adults (69 percent female) conducted from mid-March to mid-April.
The researchers found that just over one-third of respondents (34 percent) reported binge drinking during the COVID-19 pandemic. Compared with non-binge drinkers, more binge drinkers increased alcohol consumption during the pandemic (28 versus 60 percent). Every respondent had been in lockdown for four weeks, and on average, they spent 21 hours a day at home, with the majority (72 percent) not leaving for work. For every one-week increase in time spent at home during the pandemic, there were 1.21 greater odds of binge drinking when adjusting for sociodemographic factors. There were greater odds of increased alcohol consumption among binge drinkers with a previous diagnosis of depression and current depression symptoms versus those reporting no depression (adjusted odds ratio, 1.80).
"This highlights the ancillary and unintended effects of the COVID-19 pandemic which could have long-lasting population health consequences," the authors write.
© 2021 HealthDay. All rights reserved.
Posted: December 2020
Further Support and Information on COVID-19
Read this next
FRIDAY, Jan. 22, 2021 -- Treatment with bamlanivimab and etesevimab, but not monotherapy with bamlanivimab, is associated with a reduction in severe acute respiratory syndrome...
FRIDAY, Jan. 22, 2021 -- There was a decrease in the total number of pediatric emergency department visits in 2020, but the proportion of trauma-related visits increased,...
THURSDAY, Jan. 21, 2021 -- Tocilizumab plus standard care is not superior to standard care alone for improving clinical outcomes among patients with severe or critical COVID-19...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.